|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/70 | |
| G01N 33/53 | |||
| G01N 33/567 | |||
| G01N 33/00 | |||
| C07H 21/04 |
| (11) | Patento numeris | 3274478 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15888046.8 |
| Europos patento paraiškos padavimo data | 2015-06-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/036941 |
| Data | 2015-06-22 |
| (87) | Numeris | WO 2016/160046 |
| Data | 2016-10-06 |
| (30) | Numeris | Data | Šalis |
| 201562139183 P | 2015-03-27 | US |
| (72) |
CHIEN, David, Y., US
COIT, Doris, Guenzi, US
FUJIHARA, Toshiya, JP
GYENES, Alexander, US
HALL, John, Andrew, US
MEDINA-SELBY, Angelica, US
ZHENG, Jian, US
|
| (73) |
Ortho-Clinical Diagnostics, Inc.,
1001 U.S. Route 202, Raritan, NJ 08869,
US
Grifols Worldwide Operations Limited, Grange Castle Business Park Grange Castle Clondalkin, Dublin 22, IE Ortho Clinical Diagnostics, K.K., 1-11-2 Osaki Shinagawa-ku, Tokyo 141-0032, JP |
| (54) | HCV NS4A/MODIFIED NS3 POLYPEPTIDES AND USES THEREOF |
| HCV NS4A/MODIFIED NS3 POLYPEPTIDES AND USES THEREOF |